Marco Gambacciani

ORCID: 0000-0002-5453-8282 · 4 papers in corpus
review 2019
·doi:10.1080/13697137.2019.1632284

Premature ovarian insufficiency (POI) is probably one of the most devastating diagnoses for women of reproductive age. The major implications for fertility, climacteric symptoms, and quality of life, the great impact of long-term consequenc…

article 2010
Maturitas ·doi:10.1016/j.maturitas.2010.04.018

IntroductionEndometriosis is a common disease in women of reproductive age. The symptoms usually disappear after a natural or a surgical menopause. Estrogen-based hormone therapy is required in women with premature or early menopause until …

article 1997
·doi:10.1007/s002239900379

In a double-blind, placebo controlled study, ipriflavone (600 mg/day, T.D.D.) or identical placebo tablets were given with 500 mg/day of calcium to patients treated with the gonadotropin hormone-releasing hormone agonist (Gn-RH-A) leuprorel…

article 1989